Article
Blood-Based Gene Expression Signatures in Non–Small Cell Lung Cancer
11 May 2011
Abstract excerpt
PURPOSE: Blood-based surrogate markers would be attractive biomarkers for early detection, diagnosis, prognosis, and prediction of therapeutic outcome in cancer. Disease-associated gene expression signatures in peripheral blood mononuclear cells (PBMC) have been described for several cancer types. However, RNA-stabilized whole blood-based technologies would be clinically more applicable and robust. We evaluated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
